BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8822503)

  • 1. Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin.
    Takahashi M; Moriguchi S; Ikeno M; Kono S; Ohata K; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
    Peptides; 1996; 17(1):5-12. PubMed ID: 8822503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors.
    Takahashi M; Moriguchi S; Suganuma H; Shiota A; Tani F; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
    Peptides; 1997; 18(3):329-36. PubMed ID: 9145417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of oryzatensin: a novel bioactive peptide with ileum-contracting and immunomodulating activities derived from rice albumin.
    Takahashi M; Moriguchi S; Yoshikawa M; Sasaki R
    Biochem Mol Biol Int; 1994 Aug; 33(6):1151-8. PubMed ID: 7804141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of a low molecular weight agonist peptide for complement C3a receptor into soybean proglycinin A1aB1b subunit by site-directed mutagenesis.
    Takenaka Y; Utsumi S; Yoshikawa M
    Biosci Biotechnol Biochem; 2001 May; 65(5):1202-5. PubMed ID: 11440140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated.
    del Balzo U; Polley MJ; Levi R
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1003-9. PubMed ID: 2467976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The active site of C3a anaphylatoxin.
    Caporale LH; Tippett PS; Erickson BW; Hugli TE
    J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing of an orally active complement C3a agonist peptide with anti-analgesic and anti-amnesic activity.
    Jinsmaa Y; Takenaka Y; Yoshikawa M
    Peptides; 2001 Jan; 22(1):25-32. PubMed ID: 11179594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of food intake by a complement C3a agonist [Trp5]-oryzatensin(5-9).
    Ohinata K; Suetsugu K; Fujiwara Y; Yoshikawa M
    Peptides; 2007 Mar; 28(3):602-6. PubMed ID: 17207895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic actions of platelet-activating factor.
    Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
    Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylated pentapeptides antagonists of substance P on guinea-pig ileum.
    Schmitt P; Mayer M; Magneney S; Michelot R; Potier P
    Biochem Biophys Res Commun; 1988 Oct; 156(1):323-7. PubMed ID: 2460099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
    Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
    Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive peptide derived from in vitro proteolysis of bovine beta-lactoglobulin and its effect on smooth muscle.
    Pihlanto-Leppälä A; Paakkari I; Rinta-Koski M; Antila P
    J Dairy Res; 1997 Feb; 64(1):149-55. PubMed ID: 9120074
    [No Abstract]   [Full Text] [Related]  

  • 18. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
    Huey R; Erickson BW; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective hexapeptide agonists and antagonists for human complement C3a receptor.
    Scully CC; Blakeney JS; Singh R; Hoang HN; Abbenante G; Reid RC; Fairlie DP
    J Med Chem; 2010 Jul; 53(13):4938-48. PubMed ID: 20527893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antagonist peptides derived from kappa-casein.
    Chiba H; Tani F; Yoshikawa M
    J Dairy Res; 1989; 56(3):363-6. PubMed ID: 2760302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.